Kambiz Yazdi
Stock Analyst at BTIG
(3.49)
# 735
Out of 5,090 analysts
11
Total ratings
54.55%
Success rate
35.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VTVT vTv Therapeutics | Initiates: Buy | $40 | $27.35 | +46.25% | 1 | Nov 19, 2025 | |
| PRAX Praxis Precision Medicines | Initiates: Buy | $424 | $247.99 | +70.97% | 3 | Nov 19, 2025 | |
| SION Sionna Therapeutics | Initiates: Buy | $50 | $40.29 | +24.10% | 1 | Nov 19, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $47 | $29.50 | +59.32% | 1 | Nov 19, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $17.56 | +30.98% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $31.20 | -39.10% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $17.74 | -15.45% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.19 | +320.17% | 1 | Apr 12, 2024 |
vTv Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $40
Current: $27.35
Upside: +46.25%
Praxis Precision Medicines
Nov 19, 2025
Initiates: Buy
Price Target: $424
Current: $247.99
Upside: +70.97%
Sionna Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $50
Current: $40.29
Upside: +24.10%
Rapport Therapeutics
Nov 19, 2025
Initiates: Buy
Price Target: $47
Current: $29.50
Upside: +59.32%
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $17.56
Upside: +30.98%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $31.20
Upside: -39.10%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $17.74
Upside: -15.45%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.19
Upside: +320.17%